ArticleJournal for immunotherapy of cancer2026

Intrapatient variation in PD-L1 expression and tumor mutational burden and implications for outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer.

Gege Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.